PAS-004 in Patients With Advanced Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
NEXT Oncology, Austin, Texas NEXT Oncology, Irving, Texas NEXT Oncology, San Antonio, Texas NEXT Oncology, Fairfax, Virginia Romania
Institute of Oncology Bucharest Prof. Dr. Alexandru Trestioreanu, Bucharest Institute of Oncology Prof. Dr. Ion Chiricuta, Cluj-Napoca Last updated December 2025